PT3463281T - Beta-hairpin peptidomimético com atividade inibitória da elastase e respectivas formas de dosagem de aerossóis - Google Patents

Beta-hairpin peptidomimético com atividade inibitória da elastase e respectivas formas de dosagem de aerossóis

Info

Publication number
PT3463281T
PT3463281T PT177337383T PT17733738T PT3463281T PT 3463281 T PT3463281 T PT 3463281T PT 177337383 T PT177337383 T PT 177337383T PT 17733738 T PT17733738 T PT 17733738T PT 3463281 T PT3463281 T PT 3463281T
Authority
PT
Portugal
Prior art keywords
beta
dosage forms
inhibitory activity
aerosol dosage
elastase inhibitory
Prior art date
Application number
PT177337383T
Other languages
English (en)
Original Assignee
Polyphor Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polyphor Ag filed Critical Polyphor Ag
Publication of PT3463281T publication Critical patent/PT3463281T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
PT177337383T 2016-05-31 2017-05-31 Beta-hairpin peptidomimético com atividade inibitória da elastase e respectivas formas de dosagem de aerossóis PT3463281T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16020210 2016-05-31

Publications (1)

Publication Number Publication Date
PT3463281T true PT3463281T (pt) 2022-10-07

Family

ID=56108445

Family Applications (2)

Application Number Title Priority Date Filing Date
PT177337383T PT3463281T (pt) 2016-05-31 2017-05-31 Beta-hairpin peptidomimético com atividade inibitória da elastase e respectivas formas de dosagem de aerossóis
PT177337375T PT3463280T (pt) 2016-05-31 2017-05-31 Beta-hairpin peptidomimético com atividade inibitória da elastase e respectivas formas de dosagem de aerossóis

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT177337375T PT3463280T (pt) 2016-05-31 2017-05-31 Beta-hairpin peptidomimético com atividade inibitória da elastase e respectivas formas de dosagem de aerossóis

Country Status (26)

Country Link
US (3) US11235023B2 (pt)
EP (2) EP3463281B1 (pt)
JP (4) JP7286319B6 (pt)
KR (2) KR102511284B1 (pt)
CN (3) CN109310613A (pt)
AU (2) AU2017273508B2 (pt)
BR (2) BR112018074532B1 (pt)
CA (2) CA3024522A1 (pt)
CL (2) CL2018003391A1 (pt)
DK (2) DK3463281T3 (pt)
EA (2) EA039603B1 (pt)
ES (2) ES2928050T3 (pt)
HR (2) HRP20221185T1 (pt)
HU (2) HUE060393T2 (pt)
IL (2) IL263112B2 (pt)
LT (2) LT3463280T (pt)
MA (2) MA45168A (pt)
MX (2) MX2018014752A (pt)
PH (2) PH12018502522A1 (pt)
PL (2) PL3463281T3 (pt)
PT (2) PT3463281T (pt)
RS (2) RS63622B1 (pt)
SG (3) SG11201810137UA (pt)
UA (2) UA125899C2 (pt)
WO (2) WO2017207118A1 (pt)
ZA (2) ZA201807772B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE060393T2 (hu) * 2016-05-31 2023-02-28 Spexis Ag Béta-hairpin peptidomimetikum elasztáz gátló hatással és annak aeroszolos adagolási formái
BR112022014861A2 (pt) * 2020-01-30 2022-09-20 Vertex Pharma Métodos de tratamento para deficiência de alfa-1 antittripsina
MX2023005982A (es) * 2020-11-23 2023-08-15 Spexis Ag Composiciones de un peptidomimetico de horquilla beta y formas de dosificacion en aerosol del mismo.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69718047T2 (de) * 1996-11-01 2003-11-13 Xoma Technology Ltd Therapeutische verwendung von bpi proteineprodukten bei patienten mit zystischer fibrose
AU2006206272A1 (en) * 2005-01-21 2006-07-27 Alza Corporation Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion
KR101420198B1 (ko) * 2005-02-17 2014-08-13 폴리포 리미티드 프로테아제 저해 활성을 가지는 주형-고정된 β-헤어핀 구조의 펩티드모방체
EP1712220A1 (en) * 2005-04-15 2006-10-18 PARI GmbH Spezialisten für effektive Inhalation Pharmaceutical aerosol composition
DK1981572T3 (da) 2006-02-09 2013-03-04 Pari Pharma Gmbh Pulmonal afgivelse af alfa-1-proteinaseinhibitor
LT1991201T (lt) * 2006-02-10 2018-07-25 Pari Pharma Gmbh Puškiami antibiotikai inhaliaciniam gydymui
WO2008025560A1 (en) 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
EP1927373B1 (en) * 2006-11-30 2012-08-22 PARI Pharma GmbH Inhalation nebulizer
ES2532667T3 (es) 2011-09-12 2015-03-30 Meiji Seika Pharma Co., Ltd. Composiciones acuosas que contienen arbekacina
WO2015096672A1 (zh) 2013-12-23 2015-07-02 石家庄铁道大学 测试装置
JP6431486B2 (ja) 2013-12-26 2018-11-28 株式会社カネカ 太陽電池のi‐v測定方法、太陽電池のi‐v測定装置、太陽電池の製造方法、太陽電池モジュールの製造方法、および太陽電池モジュール
SI3087094T1 (sl) * 2013-12-27 2022-11-30 Spexis Ag BETA-lasnični peptidomimetiki kot selektivni zaviralci elastaze
EA034910B1 (ru) 2013-12-27 2020-04-06 Полифор Аг Бета-шпилечные пептидомиметики в качестве селективных ингибиторов эластазы
HUE060393T2 (hu) * 2016-05-31 2023-02-28 Spexis Ag Béta-hairpin peptidomimetikum elasztáz gátló hatással és annak aeroszolos adagolási formái

Also Published As

Publication number Publication date
KR20190015309A (ko) 2019-02-13
US11235023B2 (en) 2022-02-01
RS63639B1 (sr) 2022-10-31
EA201892819A1 (ru) 2019-05-31
BR112018074532A2 (pt) 2019-03-19
LT3463281T (lt) 2022-09-26
US11235024B2 (en) 2022-02-01
UA125900C2 (uk) 2022-07-06
EP3463280B1 (en) 2022-07-06
EA039603B1 (ru) 2022-02-16
EP3463281B1 (en) 2022-07-06
HRP20221185T1 (hr) 2022-12-09
CN109310613A (zh) 2019-02-05
CA3024521C (en) 2023-06-20
US11844823B2 (en) 2023-12-19
JP2023017793A (ja) 2023-02-07
CL2018003390A1 (es) 2019-05-03
IL263114A (en) 2018-12-31
KR102511284B1 (ko) 2023-03-16
MX2018014425A (es) 2019-03-28
PH12018502521A1 (en) 2019-10-21
US20200230203A1 (en) 2020-07-23
HUE060119T2 (hu) 2023-02-28
CL2018003391A1 (es) 2019-05-03
MX2018014752A (es) 2019-04-25
SG10202113280XA (en) 2021-12-30
CA3024522A1 (en) 2017-12-07
SG11201810137UA (en) 2018-12-28
UA125899C2 (uk) 2022-07-06
MA45167A (fr) 2019-04-10
EA201892818A1 (ru) 2019-05-31
HRP20221194T1 (hr) 2022-12-09
AU2017273507A1 (en) 2018-12-13
EP3463281A1 (en) 2019-04-10
KR20190011750A (ko) 2019-02-07
WO2017207118A1 (en) 2017-12-07
BR112018074532B1 (pt) 2022-02-08
RS63622B1 (sr) 2022-10-31
CN116159024A (zh) 2023-05-26
DK3463280T3 (da) 2022-09-26
JP2019523763A (ja) 2019-08-29
AU2017273507B2 (en) 2022-03-17
US20200230202A1 (en) 2020-07-23
WO2017207117A1 (en) 2017-12-07
MA45168A (fr) 2019-04-10
PL3463280T3 (pl) 2022-11-07
JP7286319B6 (ja) 2023-06-16
HUE060393T2 (hu) 2023-02-28
IL263114B2 (en) 2023-12-01
EP3463280A1 (en) 2019-04-10
PT3463280T (pt) 2022-10-07
JP7286319B2 (ja) 2023-06-05
CA3024521A1 (en) 2017-12-07
ES2927948T3 (es) 2022-11-14
AU2017273508B2 (en) 2022-07-28
IL263112B1 (en) 2023-06-01
SG11201810138XA (en) 2018-12-28
IL263114B1 (en) 2023-08-01
BR112018074551A2 (pt) 2019-03-06
IL263112A (en) 2018-12-31
PH12018502522A1 (en) 2019-10-21
JP2022078013A (ja) 2022-05-24
LT3463280T (lt) 2022-09-26
ZA201807772B (en) 2022-10-26
US20220023379A1 (en) 2022-01-27
AU2017273508A1 (en) 2018-12-13
CN109195580A (zh) 2019-01-11
KR102480800B1 (ko) 2022-12-22
BR112018074551B1 (pt) 2022-02-08
PL3463281T3 (pl) 2022-11-07
ES2928050T3 (es) 2022-11-15
DK3463281T3 (da) 2022-09-26
IL263112B2 (en) 2023-10-01
JP2019523222A (ja) 2019-08-22
ZA201807773B (en) 2022-07-27

Similar Documents

Publication Publication Date Title
IL257706A (en) Peptidomimetic macrocycles and their uses
EP3302442A4 (en) PHARMACEUTICAL FORM AND USE THEREOF
IL254444A0 (en) Peptidomimetic macrocycles and their uses
GB201516555D0 (en) Event detection and summarisation
EP3114217A4 (en) Caspase polypeptides having modified activity and uses thereof
EP3255059A4 (en) Antimicrobial peptide wy-21 and use thereof
ZA201702162B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
ZA201509326B (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
EP3250122A4 (en) Finger ring electrocardiogram monitor trigger systems and associated methods
EP3677590A4 (en) PEPTIDE WITH WRINKLE MITIGATION AND ASSOCIATED USES
EP3274922A4 (en) Reliable fingertip and palm detection
EP3418292A4 (en) PEPTIDE WITH MELANINE GENERATION ACTIVITY AND USE THEREOF
ZA201807772B (en) Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof
EP3444263A4 (en) PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF
ZA201702168B (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
EP3263584A4 (en) Peptide for targeting autophagic cells and use thereof
ZA201804864B (en) Insecticidal polypeptides having improved activity spectrum and uses thereof
EP3401326A4 (en) NOVEL PEPTIDE HAVING HYDROLYTIC ACTIVITY AND USE THEREOF
IL273655A (en) A compound with erk kinase inhibitory activity and its use
EP3500950A4 (en) MEASUREMENT AND ANALYSIS OF PHYSICAL ACTIVITY
IL283619A (en) Compounds with pde9a prophylactic activity, and their medicinal use
IL283620A (en) Compounds with pde9a prophylactic activity, and their medicinal uses
GB2568553B (en) Activity detection
GB201617761D0 (en) Medicament and assay
GB201617726D0 (en) Medicament and assay